Get the latest tech news
Pfizer, BioNTech showcase new data supporting COVID booster as strain LP.8.1 cases rise in California
The companies said their updated shot spurred an increase in neutralizing antibodies against currently circulating strains, answering calls for more corroborating evidence.
Jens Schlueter via Getty Images Pfizer and partner BioNTech said Monday their updated COVID-19 booster spurred strong immune responses against currently circulating coronavirus strains in late-stage testing, adding a key piece of evidence in support of the recently approved shot. Pfizer even added a nod to President Trump’s Operation Warp Speed initiative under which its vaccine was originally developed, claiming the program’s success is worthy of a Nobel Peace Prize. Under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., who in his short tenure has moved quickly to act on his anti-vaccine views, the federal government has substantially narrowed eligibility for COVID shots, compared to previous years.
Or read this on r/technology
